Skip to main content
Premium Trial:

Request an Annual Quote

Speak Up for Insuring Warfarin Testing

At A Forum for Improving Drug Safety, a recent blog post excerpts an email sent by Genelex CEO Howard Coleman to people interested in promoting warfarin testing. The Center for Medicare and Medicaid Services has begun a study on whether the test should be covered by insurance and is accepting public comment until tomorrow. "I believe that adherence to unreasonably difficult standards of proof for pharmacogenetic tests has resulted in harm to many, many patients," Coleman writes, directing readers to an article in GTO's sister publication, Pharmacogenomics Reporter, for background.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.